BioCryst prices 5 million share stock offering at $9.75 per share
BioCryst prices stock offering at $9.75 per share 20 years after UN pact to protect children, some successes alongside a long list of woes more images Analyst upgrades Momenta, saying he expects approval for generic clotting drug M-Enoxaparin
Momenta rises on upgrade ahead of Lovenox ruling Moody’s: credit ratings for drugmakers could be hurt as industry copes with expiring patents
Moody’s gives negative view on pharma credit Ligand Pharmaceuticals receives $2 million from research partnership with Merck
Ligand receives $2 million from Merck partnership PPD buying BioDuro for undisclosed amount in planned expansion move into China
PPD buying BioDuro in China expansion WILMINGTON, N.C. — Drug development contractor Pharmaceutical Product Development Inc. said Wednesday it will buy BioDuro LLC in a move to expand capabilities in China. Drug-delivery device maker Delcath Systems raises $32 million in share offering
Delcath Systems share offering raises $32 million Vivus shares rise as erectable dysfunction drug avanafil meets late-stage study goal
Vivus shares rise on positive avanafil study data |
Topics
Poll Loading ...Latest TweetsPharmaceutical Manufacturing
Latest Friend FeedsPharmaceutical Manufacturing
|
